Short-Term Proton Pump Inhibitor Use and Hepatic Encephalopathy Risk in Patients with Decompensated Cirrhosis

Objective: A window period of approximately 3–6 months is usually adopted in studies that evaluate hepatic encephalopathy (HE) risk in proton pump inhibitor (PPI) users. However, HE risk after short-term PPI exposure remains unclear. We explored the effect of short-term PPI exposure using a case-cro...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuan, Yi-Chun, Huang, Kuang-Wei, Lin, Cheng-Li, Luo, Jiing-Chyuan, Kao, Chia-Hung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6723586/
https://www.ncbi.nlm.nih.gov/pubmed/31349746
http://dx.doi.org/10.3390/jcm8081108

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6723586/
https://www.ncbi.nlm.nih.gov/pubmed/31349746
http://dx.doi.org/10.3390/jcm8081108

Ejemplares similares